Navigation Links
FTC Ends Investigation of CVS Caremark
Date:1/12/2012

WOONSOCKET, R.I., Jan. 12, 2012 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) announced today that the Federal Trade Commission (FTC) has concluded its investigation under the Federal Trade Commission Act into the company's business practices.  The investigation has resulted in CVS Caremark entering into a consent order that relates to certain business practices of a subsidiary of Longs Drug Stores Corporation, which took place prior to the acquisition of Longs by CVS Caremark in October 2008.  There were no allegations of antitrust law violations or anti-competitive behavior related to CVS Caremark's business practices or its products or service offerings.  In addition, the Company has received a formal letter from the FTC closing all other aspects of the investigation.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

Pursuant to the consent order, CVS Caremark will deposit $5 million into a fund that will be used to compensate consumers who purchased coverage for the 2008 plan year from a Medicare Part D Prescription Drug Plan sponsored by Rx America, a subsidiary of Longs.  The fund is being established as a result of Rx America inadvertently posting on a website maintained by the Centers for Medicare and Medicaid Services (CMS) inaccurate pricing information for certain generic drugs.  In addition, CVS Caremark agreed on a go forward basis to refrain from making any misrepresentations regarding drug pricing information relating to affiliate sponsored Medicare Part D plans. The consent order will be published in the Federal Register and is subject to comment for 30 days.

"CVS Caremark is pleased to have reached an agreement with the FTC that ends the investigation and enables us to continue our focus on offering unique, innovative products a
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
3. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
6. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
7. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
8. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
11. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... the Barclays 2015 Annual Healthcare Conference on March 10 ... Dan Brennan , executive vice president and chief ... Investor Relations, will participate in a 25-minute question and ... at approximately 1:05 p.m. ET. Following a 5-minute break, ...
(Date:2/27/2015)... --  Synageva BioPharma Corp. (Synageva) (NASDAQ: ... products for rare diseases, joins the National Organization ... Rare Diseases™ (EURORDIS™), The Global Genes Project™, and ... Day. On the last day of ... participants conduct special events to raise awareness and ...
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the ... company, today announced financial results for its first quarter ... three months ended December 31, 2014, revenue was $1,336,685. ... was $229,820 or $0.02 per share.  ... "I am very pleased with the significant progress we ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... MOUNTAIN VIEW, Calif. , Aug. 3 ... today announced it has been ranked in the top three ... to KLAS, a research firm specializing in monitoring and reporting ... the healthcare field, ZONARE has emerged as a real option ...
... HAIKOU CITY, China , Aug. 3 /PRNewswire-Asia-FirstCall/ -- ... which develops,manufactures, and markets specialty pharmaceutical products in China , today,announced that ... on Tuesday, August 10, 2010 . , ... The Company will hold a conference ...
Cached Medicine Technology:ZONARE Ranks in Top 3 in KLAS 2010 Ultrasound Report 2ZONARE Ranks in Top 3 in KLAS 2010 Ultrasound Report 3China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010 2China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010 3
(Date:2/27/2015)... 27, 2015 In New York City, ... by providing free dental care from his Sheepshead Bay­neighborhood ... with Dentistry from the Heart, and will be hosting ... first 50 patients who are in need of fillings, ... will have access to high­quality service of Dr. Umanoff's ...
(Date:2/27/2015)... Royal River Natural Foods, a locally-owned independent natural health store ... who got the most magnesium were less than half as ... got the least magnesium, with the largest benefit in those ... of the March 2015 issue of “ Natural Insights for ... each month for the Freeport community to learn more about ...
(Date:2/27/2015)... Legislation passed today by the ... provision to help prevent inappropriate prescriptions in Medicare ... Protecting the Integrity of Medicare Act (PIMA), introduced ... Brady (R-TX) and Ranking Member Jim McDermott (D-WA), ... abuse epidemic and implement the right policies, said ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on the ... Upper East Side, was officially dedicated and blessed at a ... Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, chairman ... of the ArchCare Board of Trustees, presided over the event ... of MMW, and Christina McInerney, president and CEO of The ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Mediaplanet today ... “Blood Health,” a campaign that aims to bring blood ... health care conversation. The stories in this edition go ... world of clinical care, hard-hitting advocacy, research and technological ... , According the American Cancer Society, approximately every ...
Breaking Medicine News(10 mins):Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2
... Extension of the Philadelphia Ronald McDonald House, will ... House-Lighting Ceremony on, Thursday, January 3rd; ... PHILADELPHIA, Dec. 28 The 27,000-square-foot,three-story "Philadelphia ... open its doors on Monday, January 7, 2008 ...
... To Renew and Fulfill Their,Resolutions, NEW YORK, Dec. ... fail after two months., In an effort to ... resolutions, the Healthy Monday initiative, an organization that,dedicates Monday ... a unique New Year,s idea to all Americans., ...
... farm women has shown that contact with some commonly used ... asthma. , Farm women are an understudied occupational group, ... Health Sciences and lead author of the study. More than ... is very little known about the risks. , The study ...
... attributed to pilot error significantly declined between 1983 and ... the Johns Hopkins Bloomberg School of Public Health. While ... that time, the proportion of mishaps involving pilot error ... a pilots poor decision-making declined 71 percent. The researchers ...
... Philadelphia, December 28, 2007 Laser surgery to correct ... 1990s. Photorefractive Keratotomy (PRK) is typically used to correct ... is preferred for high myopia corrections. Although over 18 ... still some controversy regarding the maximum correction possible and ...
... Mansfield Methodist Medical,Center is one year old today ... into,the world, performed 1,600 surgeries, and treated nearly ... the largest employers in Mansfield with more,than 400 ... addition,278 independently practicing physicians have joined the medical ...
Cached Medicine News:Health News:'Philadelphia Ronald McDonald House(R) at Front & Erie' Celebrates Grand Opening 2Health News:The Healthy Monday Movement Offers a Unique New Year's Idea to All Americans 2Health News:Handling pesticides associated with greater asthma risk in farm women 2Health News:Pilot error declines as factor in airline mishaps 2Health News:LASIK works well, according to long-term study of highly myopic patients 2Health News:Methodist Mansfield Celebrates First Year 2Health News:Methodist Mansfield Celebrates First Year 3
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
The edge-to-edge clarity of the laparoscopes provides excellent image definition.Even small structures are easily recognized due to the optimal depth of focus. The outstanding optical quality provide...
Stryker bariatric laparoscopes set the standard in picture quality....
Medicine Products: